Search Results - "Kopia, Gregory A."

Refine Results
  1. 1

    Twenty-eight-day efficacy and phamacokinetics of the sirolimus-eluting stent by Klugherz, Bruce D, Llanos, Gerard, Lieuallen, Warren, Kopia, Gregory A, Papandreou, George, Narayan, Pallassana, Sasseen, Brett, Adelman, Steven J, Falotico, Robert, Wilensky, Robert L

    Published in Coronary artery disease (01-05-2002)
    “…BACKGROUNDIn-stent restenosis is caused by neointimal hyperplasia. Sirolimus (rapamycin; Wyeth Research, Radnor, Pennsylvania, USA) inhibits vascular smooth…”
    Get full text
    Journal Article
  2. 2

    Biocompatibility, bone healing, and safety evaluation in rabbits with an IlluminOss bone stabilization system by McSweeney, Amanda L., Zani, Brett G., Baird, Rose, Stanley, James R. L., Hayward, Alison, Markham, Peter M., Kopia, Gregory A., Edelman, Elazer R., Rabiner, Robert

    Published in Journal of orthopaedic research (01-10-2017)
    “…ABSTRACT Bone healing, biocompatibility, and safety employing the IlluminOss System (IS), comprised of an inflatable balloon filled with photopolymerizable…”
    Get full text
    Journal Article
  3. 3

    Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model by CARTER, Andrew J, AGGARWAL, Meenakshi, KOPIA, Gregory A, TIO, Fermin, TSAO, Philip S, KOLATA, Ron, YEUNG, Alan C, LLANOS, Gerald, DOOLEY, John, FALOTICO, Robert

    Published in Cardiovascular research (01-09-2004)
    “…Stent-based delivery of sirolimus (SRL) has shown reduction in neointimal hyperplasia and restenosis. The purpose of this study was to evaluate the chronic…”
    Get full text
    Journal Article
  4. 4

    TCT-552 Particulates from Hydrophilic Coated Guiding Sheaths Embolize to the Brain by Stanley, James, Regan, Kathryn, LaRochelle, Alan, Zani, Brett, Markham, Peter, Bailey, Lynn, Spognardi, Anna-Maria, Wong, Gee, Tzafriri, Abraham R, Kopia, Gregory A, Edelman, Elazer

    “…Results The Cook guiding sheath was associated with intravascular accumulation of an amorphous, non-refractile, non-crystalline, and non-birefringent embolic…”
    Get full text
    Journal Article
  5. 5

    Evaluation of an intramedullary bone stabilization system using a light-curable monomer in sheep by Zani, Brett G., Baird, Rose, Stanley, James R. L., Markham, Peter M., Wilke, Markus, Zeiter, Stephan, Beck, Aswin, Nehrbass, Dirk, Kopia, Gregory A., Edelman, Elazer R., Rabiner, Robert

    “…Percutaneous intramedullary fixation may provide an ideal method for stabilization of bone fractures, while avoiding the need for large tissue dissections…”
    Get full text
    Journal Article
  6. 6

    Particulates from hydrophilic-coated guiding sheaths embolise to the brain by Stanley, James R L, Tzafriri, Abraham R, Regan, Kathryn, LaRochelle, Alan, Wong, Gee, Zani, Brett G, Markham, Peter M, Bailey, Lynn, Spognardi, Anna, Kopia, Gregory A, Edelman, Elazer R

    Published in EuroIntervention (01-03-2016)
    “…We sought to evaluate the incidence of embolic material in porcine brains following vascular interventions using hydrophilic-coated sheaths. A new…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Safety and pharmacokinetics of sirolimus-eluting stents in the canine cerebral vasculature: 180 day assessment by Levy, Elad I, Hanel, Ricardo A, Tio, Fermin O, Garlick, David S, Bailey, Lynn, Cunningham, Mark R, Williard, Clark, Sherman, Darren, Dooley, John F, Kopia, Gregory A

    Published in Neurosurgery (01-10-2006)
    “…We evaluated local and systemic pharmacokinetics and pharmacodynamics of sirolimus-eluting stents (SES) in canine cerebral vessels. SES (1.5 x 8 mm, 79…”
    Get full text
    Journal Article
  9. 9

    Update on sirolimus drug-eluting stents by Kipshidze, Nicholas, Leon, Martin B, Tsapenko, Mykola, Falotico, Robert, Kopia, Gregory A, Moses, Jeffrey

    Published in Current pharmaceutical design (01-01-2004)
    “…Percutaneous transluminal coronary angioplasty (PTCA) has become the main method of coronary revascularization. However, despite technical advancement,…”
    Get more information
    Journal Article
  10. 10

    Segmental vessel wall shear stress and neointimal formation after sirolimus-eluting stent implantation: physiological insights in a porcine coronary model by Carter, Andrew J., Wei, Wei, Gibson, Lori, Collingwood, Robin, Tio, Fermin, Dooley, John, Kopia, Gregory A.

    Published in Cardiovascular revascularization medicine (01-04-2005)
    “…Low vessel-wall shear stress promotes atherosclerosis and restenosis. We conducted serial analysis of vessel-wall shear stress following placement of metal and…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Importance of receptor regulation in the pathophysiology and therapy of congestive heart failure by Ruffolo, Jr, R R, Kopia, G A

    Published in The American journal of medicine (28-02-1986)
    “…The available data indicate that the beta-adrenergic receptors that mediate positive inotropic responses undergo "down-regulation," a cellularly mediated…”
    Get more information
    Journal Article
  13. 13

    Antagonism of vasopressin-induced coronary artery constriction by the vasopressin antagonist d(CH2)5Tyr(Me)-AVP by Kopia, G A, Valocik, R E

    Published in Journal of cardiovascular pharmacology (01-09-1985)
    “…d(CH2)5Tyr(Me)-AVP is a potent inhibitor of the systemic vasoconstrictor action of vasopressin (AVP). In order to examine the effectiveness of this agent in…”
    Get more information
    Journal Article
  14. 14

    Evaluation of the acute hemodynamic effects and pharmacokinetics of coronary thrombolysis produced by intravenous tissue-type plasminogen activator in the anesthetized dog by Kopia, G A, Kopaciewicz, L J, Fong, K L, Crysler, C S, Boyle, K, Ruffolo, Jr, R R

    Published in Journal of cardiovascular pharmacology (01-09-1988)
    “…The thrombolytic dose-response effectiveness and pharmacokinetics of tissue-type plasminogen activator (rt-PA) was evaluated in anesthetized, open-chest dogs…”
    Get more information
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18

    Antiarrhythmic and electrophysiologic actions of clofilium in experimental canine models by Kopia, G A, Eller, B T, Patterson, E, Shea, M J, Lucchesi, B R

    Published in European journal of pharmacology (08-10-1985)
    “…Clofilium was studied in three experimental models. In non-ischemic and chronically infarcted canine hearts, clofilium (0.5-2 mg/kg) produced a dose-dependent…”
    Get more information
    Journal Article
  19. 19

    Antifibrillatory action of bretylium: role of the sympathetic nervous system by Kopia, G A, Lucchesi, B R

    Published in Pharmacology (1987)
    “…This study was performed to assess the role of cardiac sympathetic nerves in the in vivo antifibrillatory action of bretylium using the technique of…”
    Get more information
    Journal Article
  20. 20

    Cardiac arrhythmias induced by guanethidine in cats anesthetized with halothane by Condouris, G A, Kopia, G A

    Published in European journal of pharmacology (05-12-1980)
    “…Rapid i.v. administration of guanethidine provokes severe and sustained ventricular arrhythmias in cats anesthetized with halothane. The arrhythmias include…”
    Get more information
    Journal Article